Modulatory Effects of Dietary Amino Acids on Neurodegenerative Diseases (Q47932655)

6 February 2018

title

Modulatory Effects of Dietary Amino Acids on Neurodegenerative Diseases (English)

1 reference

6 February 2018

1 reference

Senthilkumar Rajagopal

1

1 reference

6 February 2018

Supraj Raja Sangam

2

1 reference

6 February 2018

Shubham Singh

3

1 reference

6 February 2018

Venkateswara Rao Joginapally

4

1 reference

6 February 2018

publication date

1 January 2016

1 reference

6 February 2018

published in

Advances in neurobiology

1 reference

6 February 2018

volume

12

1 reference

6 February 2018

page(s)

401-414

1 reference

6 February 2018

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Oxidants are a major contributor to aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Oleic acid ameliorates amyloidosis in cellular and mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Cytokines, stress and depressive illness: brain‐immune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

5-hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading. I. Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Physical frailty predicts future cognitive decline — A four-year prospective study in 2737 cognitively normal older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

The blood-brain barrier and immune function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Protein intake and incident frailty in the Women's Health Initiative observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Glutaric aciduria type I: outcome following detection by newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Biological effects of arginine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Serotonin, eating behavior, and fat intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Cerebrospinal fluid ascorbic acid levels in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Obesity, body fat distribution, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Serine-deficiency syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Continuing education in neurometabolic disorders--serine deficiency disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Large neutral amino acids: dietary effects on brain neurochemistry and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

The ketogenic diet: from molecular mechanisms to clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Neuroprotective and disease-modifying effects of the ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Beneficial effects of alpha-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

The neuropharmacology of the ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Inositol trisphosphate receptor Ca2 release channels in neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Inositol trisphosphate receptor Ca2 release channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Excitatory amino acids as a final common pathway for neurologic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Neurological disorders presenting mainly in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

d-serine levels in Alzheimer's disease: implications for novel biomarker development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Copper and iron disorders of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Neuroprotective signal transduction: relevance to stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Barriers in the brain: a renaissance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Nutritional therapies for mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

CSF levels of carnitine in children with meningitis, neurologic disorders, acute gastroenteritis, and seizure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Literature review on the role of dietary protein and amino acids in cognitive functioning and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Amino acids and proteins in relation to the nutrition of elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Perinatal choline influences brain structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Choline: an essential nutrient for public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Isolation and Characterization of a Compound from the Urine of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Post-ischemic changes of [3H]glycine binding in the gerbil brain after cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Relationships between phenylalanine hydroxylation and plasma aromatic amino acid concentrations in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Effect of asparagine, glutamine and insulin on cerebral amino acid neurotransmitters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Role of copper in human neurological disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Role of precursor availability in control of monoamine biosynthesis in brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Protein consumption increases tyrosine concentration and in vivo tyrosine hydroxylation rate in the light-adapted rat retina

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

A subtracted probe derived from lymphocytes of twins discordant for schizophrenia hybridizes to selective areas of rat brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Cancer prevention: epidemiology and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Glutamate as a neurotransmitter in the brain: review of physiology and pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Increased CSF amino acids and ventricular enlargement in schizophrenia: a preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Regulation and dysregulation of glutamate transporters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

A molecular model of human branched-chain amino acid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

Glycine regulation of synaptic NMDA receptors in hippocampal neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-28383-8_22

10.1007/978-3-319-28383-8_22

31 March 2020

Identifiers

DOI

1 reference

6 February 2018

release_mmc3uyjv5jf33pzqsuwel7eehm

Fatcat ID

0 references

1 reference

6 February 2018